Ananda Pharma Plc — Investor Presentation 2023

Nov 8, 2023

National Storage Mechanism | Additional information

RNS Number : 6884S

Ananda Developments PLC

08 November 2023

8 November 2023

ANANDA DEVELOPMENTS PLC

("Ananda" or the "Company")

Investor Presentation via Investor Meet Company

Ananda Developments Plc ('Ananda') is pleased to announce that Melissa Sturgess, Chief Executive Officer, will provide a live presentation update on Ananda via Investor Meet Company on Tuesday 14th November at 9:00am GMT. The presentation follows the Company's recent announcements and Investival Showcase presentation in London on Monday 13th November.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet ANANDA DEVELOPMENTS PLC via:

https://www.investormeetcompany.com/ananda-developments-plc/register-investor

Investors who already follow ANANDA DEVELOPMENTS PLC on the Investor Meet Company platform will automatically be invited.

The video will also be available for viewing after the event on the Company's website and YouTube channel (https://www.youtube.com/@anandadevelopmentsplc7440).

To stay abreast of the latest developments at Ananda, we encourage you to follow our social media channels which are:  

·      Instagram: https://instagram.com/anandadevelopments?igshid=YmMyMTA2M2Y=    

·      LinkedIn: https://www.linkedin.com/company/anadevelopments/    

·      Twitter: https://twitter.com/anandaplc?s=21&t=9yeIC_xYCfzgDn7j26sfuA    

-Ends-

The Directors of the Company accept responsibility for the contents of this announcement.

ANANDA DEVELOPMENTS PLC	+44 (0)7463 686 497
	[email protected]
Chief Executive Officer
Melissa Sturgess
Executive Director
Jeremy Sturgess-Smith
SP ANGEL CORPORATE FINANCE LLP	+44 (0)20 3470 0470
Corporate Finance
Richard Morrison
Harry Davies-Ball
Corporate Broking
Abigail Wayne
Rob Rees

About Ananda Developments

Ananda is an AQSE-listed company whose ambition is to be a leading provider of cannabinoid-based medicines for the treatment of complex, chronic inflammatory pain conditions.

For more information, please visit: https://anandadevelopments.com/

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRABLBDBXDGDGXR